Ten-Fold Elevation of Chromogranin A Level Unrelated to a Neuroendocrine Tumor: A Case Report of the Diagnostic Interference of Proton Pump Inhibitors

Chromogranin A (CgA) is a well-known biomarker for neuroendocrine tumors (NETs). However, due to its non-specificity, a proper assessment of CgA test results requires a detailed knowledge of the factors, conditions, and medications influencing its serum concentration. We describe a case of a 61-year...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkhayat, Maha J, Davis, Kaamela, Atkins, Sarah J, Sheikh, Asad A, Saif, Muhammad W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637770/
https://www.ncbi.nlm.nih.gov/pubmed/37954718
http://dx.doi.org/10.7759/cureus.46862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637770/
https://www.ncbi.nlm.nih.gov/pubmed/37954718
http://dx.doi.org/10.7759/cureus.46862

Ejemplares similares